Browsing by Author Llombart Cussac, Antonio
Showing results 1 to 14 of 14
| Issue Date | Title | Author(s) |
|---|---|---|
| 11-Jul-2023 | A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer | Sampayo Cordero, Miguel; Miguel Huguet, Bernat; Malfettone, Andrea; López Miranda, Elena; Gion, María; Abad Adán, Elena; Alcalá López, Daniel; Pérez Escuredo, Jhudit; Pérez García, José Manuel; Llombart Cussac, Antonio; Cortés, Javier |
| 3-Jan-2022 | Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer | Prat Aparicio, Aleix; Guarneri, Valentina; Pascual, Tomás; Brasó Maristany, Fara; Sanfeliu, Esther; Paré Brunet, Laia; Schettini, Francesco; Martínez, Debora; Jares Gerboles, Pedro; Griguolo, Gaia; Dieci, Maria Vittoria; Cortés, Javier; Llombart Cussac, Antonio; Conte, Benedetta; Marín Aguilera, Mercedes; Chic Ruché, Núria; Puig Butillé, Joan Anton; Martínez, Antonio; Galván, Patricia; Tsai, Yi-Hsuan; González Farré, Blanca; Mira, Aurea; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S.; Conte, Pierfranco; Perou, Charles M. |
| 19-Mar-2021 | Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer | Griguolo, Gaia; Serna, G.; Pascual, Tomás; Fasani, R.; Guardia, X.; Chic Ruché, Núria; Paré, Laia; Pernas, Sònia; Muñoz Mateu, Montserrat; Oliveira, Mafalda; Vidal, M.; Llombart Cussac, Antonio; Cortés, Javier; Galván, Patricia; Bermejo de las Heras, Begoña; Martínez, N.; López, R.; Morales, Serafín; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, E.; Villagrasa, Patricia; Prat Aparicio, Aleix; Nuciforo, Paolo |
| 1-Aug-2024 | Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer | Di Cosimo, Serena; Pérez García, José Manuel; Bellet, Meritxell; Dalenc, Florence; Gil Gil, Miguel J.; Ruiz Borrego, Manuel; Gavilá, Joaquín; Aguirre, Elena; Schmid, Peter; Marmé, Frederik; Gligorov, Joseph; Schneeweiss, Andreas; Albanell, Joan; Zamora, Pilar; Wheatley, Duncan; Martínez De Dueñas, Eduardo; Amillano, Kepa; Shimizu, Eileen; Sampayo Cordero, Miguel; Cortés, Javier; Llombart Cussac, Antonio |
| 9-Oct-2024 | Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial | Fullana, Bartomeu; Morales, Serafín; Petit, Anna; Alay, Ania; Verdaguer, Helena; Climent, Fina; Navarro Perez, Valentí; Cejuela, Mónica; Galvan, Patricia; Gumà, Anna; Llombart Cussac, Antonio; Cordero, David; Casanovas, Oriol; Prat Aparicio, Aleix; Gil Gil, Miguel; Pernas, Sonia |
| 1-Dec-2024 | Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: the NOBROLA phase 2 study | Cortés, Alfonso; López Miranda, Elena; Fernández Ortega, Adela; Carañana, Vicente; Servitja, Sonia; Urruticoechea, Ander; Lema Roso, Laura; Márquez, Antonia; Lazaris, Alexandros; Alcalá López, Daniel; Mina, Leonardo; Gener, Petra; Rodríguez Morató, Jose; Antonarelli, Gabriele; Llombart Cussac, Antonio; Pérez García, José; Cortés, Javier |
| 27-Sep-2022 | Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial | Albanell Mestres, Joan; Pérez García, José Manuel; Gil Gil, Miguel; Curigliano, Giuseppe; Ruíz Borrego, Manuel; Comerma, Laura; Gibert, Joan; Bellet Ezquerra, Meritxell; Bermejo, Begoña; Calvo, Lourdes; Haba, Juan de la; Espinosa, Enrique; Minisini, Alessandro Marco; Quiroga Garcia, Vanesa; Santaballa Bertrán, Ana; Mina, Leonardo; Bellosillo Paricio, Beatriz; Rojo, Federico; Menéndez, Silvia; Sampayo Cordero, Miguel; Popa, Crina; Malfettone, Andrea; Cortés, Javier; Llombart Cussac, Antonio |
| 20-Jan-2020 | Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade | Brasó Maristany, Fara; Griguolo, Gaia; Pascual, Tomás; Paré, Laia; Nuciforo, Paolo; Llombart Cussac, Antonio; Bermejo de las Heras, Begoña; Oliveira, Mafalda; Morales, Serafín; Martínez, Noelia; Vidal Losada, Maria Jesús; Adamo, Barbara; Martínez, Olga; Pernas, Sònia; López, Rafael; Muñoz Mateu, Montserrat; Chic Ruché, Núria; Galván, Patricia; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, Eduardo; Gregorio, Sara; Gomis, Roger R.; Villagrasa, Patricia; Cortés, Javier; Ciruelos, Eva; Prat Aparicio, Aleix |
| 1-Oct-2020 | Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype | Lope, Virginia; Guerrero Zotano, Ángel; Casas, Ana; Baena Cañada, José Manuel; Bermejo, Begona; Pérez Gómez, Beatriz; Criado Navarro, Inmaculada; Antolín, Silvia; Sánchez Rovira, Pedro; Ramos Vázquez, Manuel; Antón, Antonio; Castelló, Adela; García Saenz, Jose Angel; Muñoz Mateu, Montserrat; Juan, Ana de; Andrés, Raquel; Llombart Cussac, Antonio; Hernando, Blanca; Franquesa, Rosa María; Caballero, Rosalía; Priego Capote, Feliciano; Martón, Miguel; Pollán, Marina |
| 22-Jun-2021 | The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis” | Sampayo Cordero, Miguel; Miguel Huguet, Bernat; Malfettone, Andrea; Pérez García, José Manuel; Llombart Cussac, Antonio; Cortés, Javier; Pardo, Almudena; Pérez López, Jordi |
| 1-Jul-2021 | The role of CDK4/6 inhibitors in early breast cancer | Gil Gil, Miguel; Alba, Emilio; Gavilá, Joaquín; Haba Rodríguez, Juan de la; Ciruelos, Eva; Tolosa, Pablo; Candini, Daniele; Llombart Cussac, Antonio |
| 1-Sep-2020 | The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II) | Sampayo Cordero, Miguel; Miguel Huguet, Bernat; Malfettone, Andrea; Pérez García, José Manuel; Llombart Cussac, Antonio; Cortés, Javier; Pardo, Almudena; Pérez López, Jordi |
| 27-Oct-2022 | Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain study | Pérez García, José Manuel; Gebhart, Geraldine; Borrego, Manuel Ruiz; Schmid, Peter; Marmé, Frederik; Prat Aparicio, Aleix; Dalenc, Florence; Kerrou, Khaldoun; Colleoni, Marco; Braga, Sofía; Malfettone, Andrea; Sampayo Cordero, Miguel; Cortes, Javier; Llombart Cussac, Antonio |
| 1-Dec-2020 | Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial | López Miranda, Elena; Pérez García, José Manuel; Cosimo, Serena Di; Brain, Etienne; Ravnik, Maja; Escrivá de Romaní, Santiago; Vidal Losada, Maria Jesús; Gligorov, Joseph; Borstnar, Simona; Calabuig, Laura; Sampayo-Cordero, Miguel; Malfettone, Andrea; Llombart Cussac, Antonio; Suter, Thomas M.; Cortés, Javier |